World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12616000044426
Date of registration: 19/01/2016
Prospective Registration: No
Primary sponsor: Hospital Virgen Macarena
Public title: A Specialized Physiotherapy Intervention in Patients with Amyotrophic Lateral Sclerosis from the beginning of the disease. Influence of this intervention on functional status, respiratory function, quality of life and hospitalization rate.
Scientific title: ‘An early specialized physiotherapy intervention: influence on functional status, respiratory function, respiratory complication and hospitalization rate in Patients with Amyotrophic Lateral Sclerosis’
Date of first enrolment: 02/01/2012
Target sample size: 30
Recruitment status: Active, not recruiting
URL:  https://anzctr.org.au/ACTRN12616000044426.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Non-randomised trial; Masking: Open (masking not used);Assignment: Parallel;Type of endpoint: Efficacy;  
Phase:  Not Applicable
Countries of recruitment
Spain
Contacts
Name: Mrs Anja Hochsprung   
Address:  Hospital Virgen Macarena Avenida Doctor Frediani 3, planta septima C, 41003 Seville Spain
Telephone: +34 671562074
Email: ahalcala@hotmail.com
Affiliation: 
Name: Mrs Anja Hochsprung   
Address:  Hospital Virgen Macarena Avenida Doctor Frediani 3,planta septima C, 41003 Seville Spain
Telephone: +34 671562074
Email: ahalcala@hotmail.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Key Inclusion Criteria were: diagnosis of ELA established by El Escorial criteria, including in the category of definite or probable; ability and willing to comply with the study procedures and the follow-up requirements; given written informed consent.
Exclusion criteria: The Exclusion Criteria were: severe unstable medical condiction (with possibility of life threatening complications), fronto-temporal’s dementia; no ability and not willing to comply with the study procedures and follow-up requirements.

Age minimum: 18 Years
Age maximum: No limit
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Physical Medicine / Rehabilitation - Physiotherapy
Neurological - Neurodegenerative diseases
Amyotrophic Lateral Sclerosis;
Amyotrophic Lateral Sclerosis
Intervention(s)
An individual sixty minutes intervention of Physiotherapy one per week from the beginning of the disease until the death of the patient.The intervention covers the whole group of deteriorated functions that each patient has:
- Chest physiotherapy to increase or preserve the pulmonary function: re-education of respiratory patterns, use of a volume-oriented device, use of manually assisted and unassisted coughing techniques and finally, use of a cough-assist device.
- Conventional Physiotherapy to preserve the ability to walk, the physical balance and the aerobic capacity: Static Cycle Bike for hands and legs, treadmill with suspension system to preserve the walk function and vibratory platform (Zeptor).
- Conventional Physiotherapy to preserve the whole range of movements: active and passive mobilization, manual therapy as well as stretching.
- Manual Therapy and Kinesiotaping to prevent the pain.
-Electro-stimulation in the swallowing muscles to preserve the swallowing and speech ability.

Primary Outcome(s)
Walking assessed by GAITRiter Systems[Before the intervention and every month during the intervention]
Forced Espiratory Volume assessed by Spirometry WelchAllyn[Before the intervention and every month during the intervention]
Forced Vital Capacity assessed by Spirometry WelchAllyn[Before the intervention and every month during the intervention]
Secondary Outcome(s)
Pain assessed by McGill Pain Questionnaire[Before the intervention and every month during the intervention]
Quality of life assessed with the Revised Amyotrophic Lateral Sclerosis Functional Rating scale and with the Modified Barthel Index by Granger[Before the intervention and every month during the intervention]
Peak Flow assessed by peak flow meter (Inaladuo).[Before the intervention and every month during the intervention]
Muscle activity assesses by Superficial Electromyography assessed by Neurotrac ETS[Before the intervention and every month during the intervention]
Rate of Hospitalization assessed by review of hospital records.[Before the intervention and every month during the intervention]
Number of Pulmonary Complication assessed with verbal self-report by participant at monthly assessment[Before the intervention and every month during the intervention]
Oxygen saturation assessed by pulse oximeter (Quirumed)[Before the intervention and every month during the intervention]
Secondary ID(s)
'Nil know'
Source(s) of Monetary Support
Hospital Virgen Macarena
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Comite di Etica de Investigacion (CEI) de centro Hospital Universitario Virgen Macarena.
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history